A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity (Q46899234)
Jump to navigation
Jump to search
scientific article published in March 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity |
scientific article published in March 2006 |
Statements
1 reference
A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity (English)
1 reference
P N Kumar
1 reference
A Rodriguez-French
1 reference
M A Thompson
1 reference
K T Tashima
1 reference
D Averitt
1 reference
P G Wannamaker
1 reference
V C Williams
1 reference
M S Shaefer
1 reference
G E Pakes
1 reference
K A Pappa
1 reference
ESS40002 Study Team
1 reference
1 March 2006
1 reference
1 reference
7
1 reference
2
1 reference
85-98
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference